Skip to NavigationSkip to content

News

The FDA has authorised the availability of Sandoz’s Ziextenzo (pegfilgrastim-bmez), a biosimilar version of Amgen’s Neulasta, it has emerged.
Sanofi’s quadrivalent influenza vaccine Fluzone High Dose has secured FDA approval in adult patients over the age of 65 for the prevention of two A...
RedHill Biopharma is celebrating after the FDA chose to award marketing authorisation to Talicia (omeprazole magnesium, amoxicillin and rifabutin)...
With the release of its Q3 financial results, AbbVie confirmed that international revenues for its blockbuster therapy Humira (adalimumab) – the...
The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s top pick to lead the...
Shanghai Green Valley Pharmaceuticals has announced that its therapy Oligomannate (GV-971) has secured marketing approval from China's ...
Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to...
Contamination fears over Mylan's household-name anxiety drug Xanax, UKRI and BBSRC gives cash injection to cultivate pharma and biotech PhDs in the...
Elderly patients are being put at risk by prescriptions for drugs which have not been properly tested in their age group through clinical trials, a...
A new report has revealed that GPs in England are writing fewer prescriptions for antibiotics, but this has done little to halt the spread of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches